Rest your eyes or use your commute time to learn. Listen to our experts discuss the hot topics that you need to track. And get a glimpse into the personalities behind the smiles.
As risk shifts, so too does the responsibility for delivering high-quality outcomes at lower costs. In this podcast, listen in as Sally Rodriguez discusses the impact of this shift and the momentum surrounding delivery models. Sally explores what’s ahead for this changing landscape and the opportunities that await.
Avalere Health and The SCAN Foundation partner to understand the interplay between medical and non-medical issues. Listen to Avalere’s Sally Rodriguez detail September’s white paper release.
The long waiting game for ACO stakeholders is no more after CMS finally released their much-anticipated proposed ACOs Rule 2.0 on December 1, 2014. Listen to Josh Seidman dive into the most recent CMS Medicare Shared Savings Program (MSSP) Rule.
Listen to Avalere's Debbie Lucas explain the complex world of quality measurement.
As stakeholders across the healthcare spectrum continue to wait for CMS’ ACOs Rule 2.0, Avalere’s Josh Seidman takes a crack at pinpointing the much anticipated ACO policy changes.
With something as complex and as political as shared savings models in healthcare, there will always be push-back. But according to Avalere’s Josh Seidman, now is a unique opportunity for Accountable Care Organizations (ACOs) to finally succeed. Josh explains that the current healthcare infrastructure makes ACOs attainable thanks to recent changes, including increased electronic health record use, more provider comfort with comparative performance reporting, enhanced centrality of patient engagement and new incentives that reward accountability and value.
Even during these gridlocked times in Congress, certain healthcare initiatives are getting through the cracks; one of these such initiatives is 21st Century Cures.
Listen to Debbie Lucas discuss how quality measurement can lead to improvements in the quality of care and the impact on providers.
The use of quality and performance measures in public reporting, value-based purchasing, and alternative payment models is altering clinical practice by providing incentives to improve quality measures performance and provide high-value care. Debbie Lucas helps many stakeholders seek to understand these measures, assess their business impacts, and use the information to guide decision-making.
Meet Kathy Hughes who leads our Molecular Diagnostics team and has successfully advised device, diagnostics and pharmaceutical companies on optimal market access strategies for over a decade. Kathy addresses key evidentiary developments in the diagnostics space, and what she sees as the future of this evolving field.
A June 2014 Avalere survey asserts that while 90% of pharmaceutical and biotech manufacturers are offering cost-sharing assistance to exchange patients, the type of support, generosity and program structure vary widely.
In this podcast, Matt Eyles, Executive Vice President of Health Plans and Providers, gives a short preview of his upcoming MHPA presentation, Medicaid Premium Assistance Programs: Opportunities and Challenges for States and Plans.